# OnCo record minerva-prime (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/minerva-prime/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "minerva-prime" ;
  schema:name "MinerVa Prime"@en ;
  schema:alternateName "Genecast MinerVa Prime"@en, "MinerVa Prime" ;
  schema:description "Genecast's personalised blood test for leftover cancer, used to follow patients with EGFR-mutated lung cancer after surgery in the EVIDENCE trial."@en ;
  schema:url <https://onco.cc/drugs/minerva-prime/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/s41467-026-76392-9> ;
  onco:status "emerging" ;
  onco:tag "test", "mrd" ;
  onco:modality "Tumour-informed ctDNA minimal residual disease test (up to 52 variants plus a hotspot panel)" ;
  onco:related <https://onco.cc/drugs/brprophet/> ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/>, <https://onco.cc/technologies/liquid-biopsy/> ;
  onco:drugs <https://onco.cc/drugs/icotinib/> ;
  onco:companies <https://onco.cc/companies/genecast/> ;
  onco:terms <https://onco.cc/terms/mrd/>, <https://onco.cc/terms/ctdna/>, <https://onco.cc/terms/tumour-informed-assay/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-zhou-minerva-prime-evidence-nat-commun-2026/> .